FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892371430> ?p ?o ?g. }

• W2892371430 endingPage "5962" @default.
• W2892371430 startingPage "5957" @default.
• W2892371430 abstract "Olaparib is an oral poly ADP-ribose polymerase inhibitor with activity in germline BRCA1 and BRCA2 (BRCA1/2)-associated breast and ovarian cancers. There is no report about treatment with olaparib in BRCA1/2-mutated intrahepatic cholangiocarcinomas. This study is to observe the efficacy and safety of olaparib monotherapy in the refractory BRCA1/2-mutant intrahepatic cholangiocarcinoma (ICC) patient. The clinical record of a patient with BRCA2-mutated refractory advanced ICC treated with olaparib was analyzed. The patient was administered with olaparib (400 mg orally twice daily) and followed up for 11 months. The clinical tumor response was evaluated after 4 weeks of olaparib treatment, and then every 8 weeks (two treatment cycles). The patient achieved partial response confirmed by the computed tomography and the tumor marker CA19.9, CA50, and CA125 levels decreased significantly as an outcome of the treatment. The quality of life improved significantly. Major adverse events were fatigue, thrombocytopenia, leukopenia, and anemia, which were manageable with medication. The patient is still receiving treatment. Olaparib in the treatment of BRCA2-mutation-associated refractory advanced ICC patent is effective, and the adverse effects are tolerated. Large-scale studies should be conducted to further the adoption of genomic profiling, which may help clinicians identify suitable biomarkers for therapy of ICCs. A possible line of therapy is often extrapolated from case reports or small case series." @default.
• W2892371430 created "2018-09-27" @default.
• W2892371430 creator A5041445730 @default.
• W2892371430 creator A5043000778 @default.
• W2892371430 creator A5045703368 @default.
• W2892371430 creator A5055746720 @default.
• W2892371430 date "2018-09-01" @default.
• W2892371430 modified "2023-10-14" @default.
• W2892371430 title "Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report" @default.
• W2892371430 cites W1846586690 @default.
• W2892371430 cites W1974564771 @default.
• W2892371430 cites W2015613033 @default.
• W2892371430 cites W2018041848 @default.
• W2892371430 cites W2053483691 @default.
• W2892371430 cites W2072564984 @default.
• W2892371430 cites W2087336559 @default.
• W2892371430 cites W2096796171 @default.
• W2892371430 cites W2101036284 @default.
• W2892371430 cites W2108756633 @default.
• W2892371430 cites W2111437716 @default.
• W2892371430 cites W2115261608 @default.
• W2892371430 cites W2136629154 @default.
• W2892371430 cites W2139947970 @default.
• W2892371430 cites W2141042450 @default.
• W2892371430 cites W2162445014 @default.
• W2892371430 cites W2309818502 @default.
• W2892371430 cites W2329659234 @default.
• W2892371430 cites W2570618306 @default.
• W2892371430 cites W2769909737 @default.
• W2892371430 cites W2783112448 @default.
• W2892371430 doi "https://doi.org/10.2147/ott.s176914" @default.
• W2892371430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6151096" @default.
• W2892371430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30271179" @default.
• W2892371430 hasPublicationYear "2018" @default.
• W2892371430 type Work @default.
• W2892371430 sameAs 2892371430 @default.
• W2892371430 citedByCount "17" @default.
• W2892371430 countsByYear W28923714302019 @default.
• W2892371430 countsByYear W28923714302020 @default.
• W2892371430 countsByYear W28923714302021 @default.
• W2892371430 countsByYear W28923714302022 @default.
• W2892371430 countsByYear W28923714302023 @default.
• W2892371430 crossrefType "journal-article" @default.
• W2892371430 hasAuthorship W2892371430A5041445730 @default.
• W2892371430 hasAuthorship W2892371430A5043000778 @default.
• W2892371430 hasAuthorship W2892371430A5045703368 @default.
• W2892371430 hasAuthorship W2892371430A5055746720 @default.
• W2892371430 hasBestOaLocation W28923714301 @default.
• W2892371430 hasConcept C104317684 @default.
• W2892371430 hasConcept C121332964 @default.
• W2892371430 hasConcept C126322002 @default.
• W2892371430 hasConcept C142424586 @default.
• W2892371430 hasConcept C143998085 @default.
• W2892371430 hasConcept C182979987 @default.
• W2892371430 hasConcept C185592680 @default.
• W2892371430 hasConcept C197934379 @default.
• W2892371430 hasConcept C2779138821 @default.
• W2892371430 hasConcept C2779962180 @default.
• W2892371430 hasConcept C55493867 @default.
• W2892371430 hasConcept C71924100 @default.
• W2892371430 hasConcept C82381507 @default.
• W2892371430 hasConcept C87355193 @default.
• W2892371430 hasConcept C90924648 @default.
• W2892371430 hasConceptScore W2892371430C104317684 @default.
• W2892371430 hasConceptScore W2892371430C121332964 @default.
• W2892371430 hasConceptScore W2892371430C126322002 @default.
• W2892371430 hasConceptScore W2892371430C142424586 @default.
• W2892371430 hasConceptScore W2892371430C143998085 @default.
• W2892371430 hasConceptScore W2892371430C182979987 @default.
• W2892371430 hasConceptScore W2892371430C185592680 @default.
• W2892371430 hasConceptScore W2892371430C197934379 @default.
• W2892371430 hasConceptScore W2892371430C2779138821 @default.
• W2892371430 hasConceptScore W2892371430C2779962180 @default.
• W2892371430 hasConceptScore W2892371430C55493867 @default.
• W2892371430 hasConceptScore W2892371430C71924100 @default.
• W2892371430 hasConceptScore W2892371430C82381507 @default.
• W2892371430 hasConceptScore W2892371430C87355193 @default.
• W2892371430 hasConceptScore W2892371430C90924648 @default.
• W2892371430 hasLocation W28923714301 @default.
• W2892371430 hasLocation W28923714302 @default.
• W2892371430 hasLocation W28923714303 @default.
• W2892371430 hasLocation W28923714304 @default.
• W2892371430 hasLocation W28923714305 @default.
• W2892371430 hasOpenAccess W2892371430 @default.
• W2892371430 hasPrimaryLocation W28923714301 @default.
• W2892371430 hasRelatedWork W1975187426 @default.
• W2892371430 hasRelatedWork W2088376108 @default.
• W2892371430 hasRelatedWork W2606696169 @default.
• W2892371430 hasRelatedWork W2887088455 @default.
• W2892371430 hasRelatedWork W3080741188 @default.
• W2892371430 hasRelatedWork W3207301911 @default.
• W2892371430 hasRelatedWork W4210532624 @default.
• W2892371430 hasRelatedWork W4283022593 @default.
• W2892371430 hasRelatedWork W4294308226 @default.
• W2892371430 hasRelatedWork W4296006440 @default.
• W2892371430 hasVolume "Volume 11" @default.
• W2892371430 isParatext "false" @default.
• W2892371430 isRetracted "false" @default.

• next